-
UK Doctors Seek Review of 12-Week Gap Between Vaccine Doses
Britain’s main doctors’ organization says it is concerned about the U.K.’s decision to give people a second dose of coronavirus vaccine up to 12 weeks after the first, rather than the shorter gap recommended by manufacturers and the World Health Organization
-
UK Prime Minister Orders New Virus Lockdown for England
British Prime Minister Boris Johnson has announced a new national lockdown for England until at least mid-February to combat a fast-spreading new version of the coronavirus
-
UK Is First to Authorize Easy-To-Handle AstraZeneca Vaccine
Britain has become the first country to authorize AstraZeneca’s inexpensive, easy-to-handle COVID-19 vaccine
-
Biden Eyes Mask Requirement, 100 Million Vaccine Shots for First 100 Days
President-elect Joe Biden on Tuesday outlined his plan to tackle the coronavirus pandemic in his first 100 days. He said he would require masks where he could under the law, secure 100 million vaccine shots and open a majority of schools.
-
Studies Suggest AstraZeneca COVID-19 Vaccine Safe, 70% Effective
New results on a possible COVID-19 vaccine from Oxford University and drugmaker AstraZeneca suggest it is safe and about 70% effective
-
AstraZeneca Manufacturing Error Clouds Vaccine Study Results
AstraZeneca and Oxford University acknowledged a manufacturing error that is raising questions about preliminary results of their COVID-19 vaccine.
-
Testing Timeline: What's Ahead for COVID-19 Vaccines
Pfizer’s surprising news that its COVID-19 vaccine might offer more protection than anticipated is raising questions about exactly how the different shots will make it to market
-
As Potential Pfizer Vaccine Raises Hopes, Other Drug Companies Also Racing to COVID-19 Finish Line
Pfizer revealed Monday that early results from its coronavirus vaccine suggest the shots may be 90% effective at preventing COVID-19, putting the company on track to apply later this month for emergency-use approval from the Food and Drug Administration.
-
AstraZeneca, Johnson & Johnson Resume Late-Stage COVID-19 Vaccine Trials
AstraZeneca and Johnson & Johnson announced Friday that they would resume their phase 3 clinical trials on COVID-19 vaccine candidates in the U.S, NBC News reports.
-
AstraZeneca Shares Turn Negative After Brazilian Health Authority Says Volunteer in COVID Vaccine Study Dies
AstraZeneca shares turned negative Wednesday after a Brazilian health authority, Anvisa, said a volunteer in its coronavirus vaccine study died.
-
Oxford, AstraZeneca to Resume Coronavirus Vaccine Trial
Oxford University says trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side-effect in a patient in the U.K.
-
Final Phase of Vaccine Trial Paused After Neurological Symptoms Surfaced
AstraZeneca announced late Tuesday that it is pausing its crucial late-stage trial for its coronavirus vaccine candidate as a result of a patient illness. This comes a day after several companies signed a safety pledge to uphold the scientific standards that their experimental vaccines will be held against.
-
AstraZeneca Announces ‘Routine' Safety Pause in Coronavirus Vaccine Trial
AstraZeneca shares fell more than 6% in after-hours trading Tuesday after the company said its late-stage trial for a potential coronavirus vaccine had been put on hold due to safety concerns.
-
AstraZeneca Gets $1 Billion From US for COVID-19 Vaccine
Drug maker AstraZeneca secured its first agreements Thursday for 400 million doses of a COVID-19 vaccine, bolstered by an investment from the U.S. vaccine agency.
-
‘Michael Jackson Drug' Still Prompts Curiosity From Patients
It remains the most widely used anesthetic in U.S. hospitals, but many patients still remember propofol as the drug that killed Michael Jackson. Most are no longer afraid of it, doctors say, though many still ask if they will get “the Michael Jackson drug” before an operation. And most of them will. Jackson died 10 years ago at his Los...
-
‘Michael Jackson Drug' Still Prompts Curiosity From Patients
It remains the most widely used anesthetic in U.S. hospitals, but many patients still remember propofol as the drug that killed Michael Jackson. Most are no longer afraid of it, doctors say, though many still ask if they will get “the Michael Jackson drug” before an operation. And most of them will. Jackson died 10 years ago at his Los...
-
Senators Draw on Own Experiences to Chastise Drug Companies
Drawing from their personal experiences, senators on Tuesday chastised drug company executives over the high cost of prescription drugs, as the company officials cautioned that heavy-handed congressional action could jeopardize medical breakthroughs going forward. Tuesday’s Senate Finance Committee hearing marked the first time lawmakers have called the industry’s top executives to account for rising prices, which are a drain on...
-
FDA: Drug Shortages Possible Due to Puerto Rico Power Outage
The Food and Drug Administration on Friday warned that U.S. drug shortages are possible because power outages in Puerto Rico have stopped or limited production at many medicine factories there. Nearly 10 percent of the medicines used by Americans, plus numerous medical devices, are made in Puerto Rico, which lost most electricity when it was hit hard by Hurricane Maria...
-
AstraZeneca Explains Why Swine Flu Vaccine Didn't Work
The makers of the nasal spray version of the flu vaccine say now they know why it has failed to protect young U.S. children against swine flu — fragile doses got too warm.
-
Rescue of the At-Risk Vaquita Porpoise
For the first time in four years, fishermen are back on the water in the Upper Gulf of California fishing inside the vaquita marina sanctuary, the only place in the world where the smallest marine mammal can be found.